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                                            INTRODUCTION 
          Protein-energy malnutrition (PEM) is a chronic or acute lean body 
protein loss that leads to a state of specific nutrient deficiency that produces 
a measurable change in body function1. PEM is a clinical condition 
characterized by depletion of muscle/body fat and visceral proteins. PEM is 
associated with a worse outcome during illness and may be reversed by 
conversion to an anabolic state. PEM is common in hospitalized patients and 
is associated with increased mortality2,3. 30%– 60% of patients hospitalized 
for acute illness are malnourished, and nutritional status has been shown to 
deteriorate during hospitalization 4 . Reasons for this high prevalence include 
poor recognition and monitoring of nutritional status and inadequate intake 
of nutrients during hospitalization1 . Malnutrition is also major problem 
among residents in long-term care facilities. Furthermore, patients admitted 
to the hospital may already be malnourished or at risk of malnutrition5. 
          Trauma  and surgery induce extensive physiological changes, 
commonly denominated the acute phase reaction (APR). This APR is 
activated by various kinds of stimuli, namely nociceptive stimulations, tissue 
injury, tissue ischaemia and reperfusion as well as by haemodynamic 
disturbances which occur commonly in such patients. APR is mainly 
characterised by the release of counter-regulatory hormones, complex 
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metabolic changes and by the hepatic synthesis of numerous acute phase 
factors (C-reactive protein, haptoglobin, complement protein, etc).  There is 
a resistance to the nutritional  support .  In patients  with non complicated 
surgery and low or moderate severity trauma , the metabolic changes are 
minor and self-limited .  Conversely , in patients  with complicated surgery 
or major trauma , there is an extensive APR, which can be very prolonged. 
This results in important and sustained metabolic changes, leading to 
extensive catabolism and progressive loss of body cell mass. The latter is 
amplified by the decreased body ability to adapt to starvation and by the 
resistance to the nutritional  support that typically occur in complicated 
postoperative and trauma patients6. 
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AIMS AND OBJECTIVES 
 
 
The aims and objectives of the study are 
• To prospectively study the effect of major elective orthopaedic 
surgery on the nutritional status of  patients. 
• To analyse how the nutritional markers behave pre op, post op and at 
3 months follow up in patients undergoing major elective orthopaedic 
surgery. 
• To analyse the effect of nutritional status on the wound related 
complications and other post op complications like UTI. 
• To compare changes in the pattern of the nutritional parameters 
between the patients undergoing different types of major elective 
orthopedic surgery. 
• To evaluate the time taken for the nutritional parameters to normalise. 
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     REVIEW OF LITERATURE 
           Malnutrition results either from inadequate intake or increased energy 
needs during illness6. It causes loss of both body fat and lean body mass 
including muscle7. It is known that humans do not survive once their body 
cell mass    ( fat free portion of muscle, viscera, and immune system ) drops 
below 60% of the normal levels of young adult8. Thus severe wasting results 
in death. However factors such as trauma , ageing and chronic diseases that 
are not directly related to malnutrition also results in body wasting7,9.  
          The trauma of injury or surgery causes production of catabolic 
cytokines resulting in increased expenditure and break down of protein 
stores , including  muscle10. These changes support the activation of 
inflammatory and reparative mechanisms and promote recovery10-12 . 
Healthy individuals who are adequately nourished generally move through 
the catabolic phase in to the reparative phase and recover with out serious 
consequences. 
          In patients who are undernourished , especially with respect to protein, 
the nutrients required for recovery compete with those necessary for 
maintaining or restoring lean tissue mass13. If the metabolic responses are 
particularly intense or prolonged , they can result in nutritional depletion in 
undernourished patients which lead to poor clinical outcome14.Thus there 
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appear to be a fine balance between the normal metabolic response to injury 
that promotes recovery and maintaining sufficient protein reserves in the 
body to allow recovery of physical function and prevent death. 
          The effects of ageing further complicate this relationship. Ageing is 
associated with decreases in muscle mass and increased likelihood of 
chronic diseases. Thus even adequately nourished elderly people recover 
from trauma and surgery more slowly than adult15. However malnutrition is 
common in the elderly16-19. Studies in animals and humans have 
demonstrated that ageing results in defects in adaptation to long term dietary 
restrictions, manifested by more pronounced loss of weight and lean body 
mass compared to younger adults and further compromises the already 
decreased muscle function and immune response observed in the elderly20-24.  
          The catabolic state and the inflammatory reaction that occur in 
response to the trauma of  both the fracture and surgery is particularly severe 
in hip fracture patients. It persist for several months and is dramatically 
higher than in nonsurgical elderly patients25-28.  Hospitalized hip fracture 
patients have lower nutrient intake than the elderly control population29,30. 
Thus the prolonged inflammatory response may be related to the state of 
malnutrition in these patients. It results in loss of skeletal muscle mass , 
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visceral protein and immunocompetence . It could induce a downward frailty 
cycle that may lead to dysfunction or death in certain patients31,32.  
          Thus malnutrition , trauma , surgery and ageing not only contribute 
independently but also interact to promote loss of muscle mass. However   
malnutrition also results in impairment of cellular , immune and muscle 
function33,34. The changes in muscle function occur more quickly than the 
changes in the muscle mass in response to both decreased nutrient intake and 
refeeding. The changes in the muscle function are independent of the disease 
or inflammatory states caused by the trauma of injury or surgery. These 
changes in the muscle function may be more indicative of pure malnutrition 
than are the changes in the body composition35,36.  
Incidence of malnutrition in orthopaedic inpatients 
          There are various studies on the incidence of under nutrition in 
hospitalized patients. Most of them give figures around 40 %37-41. The effect 
of malnutrition in hip fractures  especially in elderly is extensively studied 
and these studies show prolonged hospital stay and complications in the 
malnourished patients42-45. 
Nutritional markers  
          The nutritional markers can be classified in to two groups 
1. Anthropometric  markers 
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2. Biochemical markers. 
            The anthropometric markers are the most widely used and non-
invasive  method of assessing the nutritional status46. The anthropometric 
markers commonly used are Body Mass Index ( BMI) , Mid Upper Arm 
Circumference ( MUAC ) and Triceps Skin Fold thickness ( TSF). 
          BMI is calculated by the following formula – 
BMI  =   Weight in kilogram 
              ( Height in metre  )2  
A value less than 19.99 is considered as undernourished. 
20 to 24.99 is considered as adequately nourished 
25 to 29.99 is considered as over weight 
30 to 39.99 is considered as obese 
>/= 40 is considered as morbidly obese 
          BMI is the most accurate form of  anthropometric  measurement for 
assessing nutrition47. 
          MUAC is measured With the subject’s forearm held in horizontal 
position. The lateral part of the upper arm is marked at the midpoint 
between the acromion process and the lateral epicondyle of the  humerus. 
Care must be  exercised to maintain the tape in a horizontal plane and to 
avoid distortion of the skin surface. The circumference is measured to the 
nearest mm at the marked midpoint48. 
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          TSF is measured by the following procedure. A fold of skin plus 
subcutaneous tissue (without underlying muscle) is formed over the triceps 
muscle with the thumb and the index finger of the non dominant hand 
at the same vertical position where the mid-upper arm circumference is 
measured. The crest of the fold is parallel to the long axis of the arm. The 
thickness of the fold is measured with a vernier caliper held in the 
dominant hand, without releasing the fold from between the thumb and the 
index finger of the non dominant hand. Measurements are recorded to the 
nearest mm39. 
           The final measurement, in both MUAC and TSF, is taken by taking 
the average of three readings. Even though they are very easy and cheap 
method,  both these measurements are highly observer dependant and are 
inaccurate39. 
            The normal values for the MUAC and TSF are the following49- 
Normal  TSF –Male -9.2 +/- 3.2 mm 
              Females -17.1 +/- 5.5 mm 
Normal  MUAC – Male -28.4 +/- 2.5 cm 
                    Females – 26.6 +/-3.5 cm 
            The biochemical markers commonly used for nutritional assessment 
are total lymphocyte count ( TLC ), albumin, prealbumin ( PA ) , transferrin 
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( TF ) .  Among these pre albumin and transferring are found to be more 
accurate in assessing the nutritional status than the others5. 
          Normal range for the biochemical markers are –  
TLC- 1000 to 3500 / dl 
Albumin -  3.4 to 5.4 g/dl 
PA - > 20 mg/dl 
TF – 200 to 400 mg/dl 
          Albumin is the most abundant blood plasma protein and is produced in 
the liver and forms a large proportion of all plasma protein.  it normally 
constitutes about 60% of human  plasma protein. It has a molecular weight 
of about 65kD (65,000 Atomic mass units) and consists of 584 amino acids 
and contains no carbohydrate. Serum albumins are important in regulating 
blood volume by maintaining the oncotic pressure(also known as colloid 
osmotic pressure) of the blood compartment. They also serve as carriers for 
molecules of low water solubility, this way isolating their hydrophobic 
nature, including lipid soluble hormones, bile salts, unconjugated bilirubin, 
free fatty acids(apoprotein), calcium, ions (transferrin), and some drugs like 
warfarin, phenobutazone, clofibrate & phenytoin. For this reason, it's 
sometimes referred as a molecular "taxi". Competition between drugs for 
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albumin binding sites may cause drug interaction by increasing the free 
fraction of one of the drugs, thereby affecting potency50,51. 
          Transferrin is a blood plasma protein for iron ion delivery that, in 
humans, is encoded by the TF gene. The liver is the main source of 
manufacturing transferrin, but other sources such as the brain also produce 
this molecule. Transferrin is a glycoprotein that binds iron very tightly but 
reversibly. Although iron bound to transferrin is less than 0.1% (4 mg) of the 
total body iron, it is the most important iron pool, with the highest rate of 
turnover (25 mg/24 h). Transferrin has a molecular weight of around 80 
kiloDaltons and contains 2 specific high-affinity Fe(III) binding sites. The 
affinity of transferrin for Fe(III) is extremely high (1023M-1 at pH 7.4) but 
decreases progressively with decreasing pH below neutrality.When not 
bound to iron, it is known as "apo-transferrin". 
           Transferrin consists of a poly peptide chain containing 679 amino 
acids. It is a complex composed of alpha helices and beta sheets to form 
two domains (the first situated in the N-terminus and the second in the C-
terminus). The N- and C- terminal sequences are represented by globular 
lobes and between the two lobes is an iron-binding site. 
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          The amino acids which bind the iron ion to the transferrin are identical 
for both lobes; two tyrosines, one histidine , and one aspartic acid. In order 
for the iron ion to bind an anion is required, preferably carbonate (CO32-). 
Transferrin also has a transferrin iron-bound receptor; it is a disulfide-
linked homodimer. In humans, each monomer consists of 760 amino acids. 
It enables ligand bonding to the transferrin, as each monomer can bind to 
one or two molecules of iron. Each monomer consists of three domains: the 
protease domain, the helical domain, and apical domain. The shape of 
transferrin receptor resembles a butterfly-like complex, due to the three 
clearly shaped domains52. 
            Prealbumin is now known as Transthyretin (TTR), a serum  and  
cerebrospinal fluid carrier of the thyroid hormone  thyroxine  (T4) and 
retinol. This is how transthyretin gained its name,  transports thyroxine 
and retinol. TTR was originally called  prealbumin because it ran faster 
than albumins on electrophoresis gels. 
            It is a 55-kDa homotetramer with a dimer of dimers configuration 
that is synthesized in the liver, choroid plexus and retinal pigment 
epithelium. Each monomer is a 127-residue polypeptide rich in beta 
sheet structure. Association of two monomers forms an extended beta 
sandwich. Further association of another identical set of monomers produces 
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the homotetrameric structure. The two thyroxine binding sites per tetramer 
sit at the interface between the latter set of dimers5. 
           In nutritional assessment pre albumin is preferred because of its 
shorter half life5. 
Combination of anthropometry and biochemical markers. 
          Creatinine – arm index ( CAI )and creatinine – height index ( CHI ) 
are used to overcome the inaccuracy found in nutritional assessment by 
either of the method alone53. 
CHI  is defined as the urinary creatinine excretion over a period of 
24 hours expressed as a percentage of the value expected to be excreted 
in normal subjects of the same height and sex.  
CAI = actual daily urinary creatinine excretion 
           expected daily urinary creatinine excretion 
 
Expected creatinine excretion = IBW x creatinine coefficient 
IBW( ideal body weight ) = (2 x WC) + (1.25 x TAL) - 40.9 
WC = Wrist circumference 
TAL = Total arm length 
Creatinine coefficient = creatinine concentration/IBW ( age and sex  
corrected) 
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Nutritional Index of Rainey-Macdonald et al. 
          Rainey-Macdonald et al developed an index based on serum albumin 
and transferrin that can help identify patients who may benefit from 
nutritional support54. 
Nutritional index  = (1.20 x (serum albumin in g/dL)) + (0.013 x (serum 
transferrin in mg/dL)) - 6.43 
Anyone with an index < 0 qualified for nutritional support. 
Nutritional assessment questionnaire 
          Mini Nutritional Assessment ( MNA ) and Subjective Global 
Assessment ( SGA ) are the two questionnaire based nutritional assessment 
tools. They both have been found to be simple, noninvasive and cost-
effective tool for assessing nutritional status of the elderly55-58 .                        
Other nutritional assessment methods. 
          DEXA measured water isotope dilution volumes and whole body 
counting / in vivo neutron activation analysis to estimate total body 
potassium are more accurate than anthropometry but  time consuming , 
expensive and invasive7. 
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          Bio electric impedence analysis ( BIA ) is an inexpensive, quick, safe 
and non invasive technique to measure body composition. It measures tissue 
conductivity which is proportional to the amount of electrolyte rich fluid 
present. All body water and fluids are bound in the fat free body mass 
component. Using population specific equations , BIA can be used to 
estimate fat free body mass under standardized conditions59,60. 
          Muscle function tests and lymphocyte mitochondrial function tests are 
the newer approaches in the nutritional assessment. The changes in the 
muscle and lymphocyte function in response to the changes in the nutrition 
occur quickly and before there are any changes in the body composition. 
They are independent of the inflammatory states too61. 
Wound related complications and nutrition. 
          The relation between wound related complications and the nutritional 
status of the patient has been extensively studied in surgical and orthopaedic 
patients. Increased incidence of wound complications in undernourished has 
been found uniformly in all the studies62-67. Nutritional supplementation was 
found to be effective in reducing wound related complications68. 
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          There are two types of  wound infection possible in orthopaedic 
patients69 – 
1. Superficial infection 
2. Deep infection 
           The superficial infection occurs within 30 days after the operation.It 
involves only the skin or subcutaneous tissue and at least 1 of the following: 
1.Purulent drainage is present (culture documentation not required). 
2.Organisms are isolated from fluid/tissue of the superficial incision. 
3.At least 1 sign of inflammation (eg, pain or tenderness, induration, 
erythema, local warmth of the wound) is present. 
4.The wound is deliberately opened by the surgeon. 
5.The surgeon or attending physician declares the wound infected. 
          The deep infection occurs within 30 days of the operation or within 1 
year if an implant is present. It Involves deep soft tissues (eg, fascia and/or 
muscle) of the incision and at least 1 of the following: 
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1.Purulent drainage is present from the deep incision but without 
organ/space involvement. 
2.Fascial dehiscence or fascia is deliberately separated by the surgeon 
because of signs of inflammation. 
3.A deep abscess is identified by direct examination or during reoperation, 
by histopathology, or by radiologic examination. 
4.The surgeon or attending physician declares that a deep incisional 
infection is present. 
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. MATERIALS AND METHODS 
          This study is a prospective descriptive study done to determine the 
effect of major elective orthopaedic surgery on the nutritional status of the 
patients. The patients included in the study are those who got admitted and 
operated under Orthopaedics unit 1 and Spinal Disorder Surgery unit , 
Christian Medical College, Vellore from February 2007 to April 2008 and 
March 2009 to September 2009. 
 
Inclusion criteria 
All patients undergoing major elective orthopaedic surgery under 
orthopaedic unit 1 and Spinal Disorder Surgery unit. Major orthopaedic 
surgery includes spine instrumentation surgeries and joint replacement 
surgeries70,71. 
 
Exclusion criteria 
1.Trauma patients. 
2.Patients admitted for tumour surgeries. 
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Sample size 
Sample size for a descriptive prospective study = Zα2 x PQ 
                                                                                     d2  
 
Zα = 1.96 for p value 0f 0.005 
 d = precision which is taken as 7 
 P = 40 .According to literature around 40 % of orthopaedic inpatients are 
malnourished37-41. 
Q = 100-P = 60 
Therefore calculated sample size is approximately 200. 
 
Nutritional assessment 
           The nutritional assessment was done by both anthropometry ( BMI) 
and biochemical markers( Prealbumin and Transferrin ). Since  MUAC and 
TSF were found to be highly observer dependant and inaccurate, they were 
not used for analysis. Similarly since prealbumin and transferrin were better 
predictors of the nutritional status ,other biochemical markers( albumin and 
total lymphocyte count) were not analysed. 
          The patients were evaluated pre op, post op ( at suture removal ) and 
at three months follow up. The Proforma was filled up for each patient 
which included demographic details, diagnosis, surgery done , comorbidities 
and the nutritional parameters.  
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          Urinary Tract Infection (UTI) referred to in our study is defined as the 
bacterial infection of  any part of the urinary tract ( urethra, bladder or 
kidney) confirmed with urine culture.Females are more at risk for UTI due 
to the anatomical differences.Paraplegics are also more at risk for UTI. In 
symptomatic patients , the diagnostic criteria are - 
1.Women: Presence of at least 100,000 colony- forming units (cfu)/mL in a 
pure culture of voided clean-catch urine. 
2.Men: Presence of  just 1,000 cfu/mL indicates urinary tract infection. 
In asymptomatic patients the diagnostic criteria are - 
1. Women :2 consecutive voided urine samples  with isolation of same strain  
in >100,000 cfu/mL. 
2.Men: single, clean-catch specimen with  bacterial species isolated in > 
100,000 cfu/mL . 
3.Single catheterized urine specimen in both men and women with 1 
bacterial species isolated in a count of > 1,000 cfu/mL . 
           The wound related complications in our study are described as either 
superficial wound infection or deep wound infection. Superficial wound 
infection is defined as the wound infection in which infection has not 
breached the deep fascia and when no surgical intervention is needed for the 
control of infection. It responds to dressings and antibiotic therapy.  Deep 
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infection is defined as the wound infection in which the infection has 
breached the deep fascia and when surgical intervention ( wash out and 
drainage) along with antibiotic therapy  is needed for the control of 
infection. 
          We have divided our patients in to two age groups for comparison -
age more than 40 yrs and less than 40 yrs. In western literature , age cut off 
for elderly age group is taken as 60 yrs15 - 24. We have taken 40 yrs as cut off 
taking in to consideration the physiological differences between our 
population and the western population. 
           The statistical analysis was done using  SPSS software version 
16.The statistical tests used were Chi square test and repeated variable 
Annova test. 
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                                             RESULTS 
Patient demographics 
         Total number of patients assessed during the above mentioned time 
period was 199. Total number of  cases followed up was 113 ( 56.78% 
follow up). 
 
Surgery done Patients seen Patients followed up 
Spine surgeries 92 51 
1.PLIF 64 33 
2.Infective Spondylitis 28 18 
Unilateral replacement 76 46 
3.THR Unilateral 50 31 
4.TKR Unilateral 26 15 
Bilateral replacement 31 16 
5.TKR Bilateral 20 11 
6.THR Bilateral 8 4 
7.Hip + Knee replacement 3 1 
Total  199 113 
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          The analysis was done on the 113 patients evaluated at the three 
months follow up. 
Age                           – 16 to 76 yrs. 
Average age             – 48.8 yrs. 
Median age               - 49.5 yrs 
Males                        – 59 pts. (52.2 %) 
Females                    – 54 pts. (47.8 %) 
Age > 40 yrs            – 86 pts. ( 76.1%) 
 
Comorbidities  
Diabetes          – 21 pts. ( 18.6%) 
Hypertension  –19 pts, (16.8%) 
 
           The bilateral THR and hip + knee replacement  groups were not 
analyzed separately because of the small number of patients followed up. 
They are included in the analysis under bilateral replacement group. 
          The number of patients with BMI less than 20( Undernourished) was 
only 5  ( 4.42 %). Prealbumin was less than 20 in 4 out of these 5 patients. 
There was no patient with transferrin value less than 200. 
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          The number of patients with BM I more than 25 ( overweight) was  38 
( 33.62 %).Prealbumin and transferrin values has been analyzed separately 
for the different surgical groups. 
 
 
 
Complications 
15 patients had wound related complications (13.3 %) – 11 superficial 
infection and 4 deep infection. 
 10  patients had urinary tract infection post op ( 8.8 % ). 
 
PLIF ( posterior lumbar interbody fusion) 
The number of patients followed up  – 33 
Age                                                     – 23 to 75 yrs. 
Average age                                        – 50.3 yrs. 
> 40 yrs age group                              – 29 pts. (87.9%) 
Females                                               – 19 pts. (57.6% ) 
Males                                                   – 14 pts. (42.4%) 
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Comorbidities 
DM  –8 pts. ( 24.2 %) 
HT  – 4 pts.( 12.1 %) 
 
BMI 
BMI < 20  – 2 pts.  ( 7.1 %) 
BMI > 25 -  13 pts.(38.4 %) 
There was no association of BMI with the incidence of  wound infection. ( 
Annexure  - tables 91,92). 
 
Analysis of  prealbumin in PLIF group 
         The pre albumin values at pre op , post op and follow up of the PLIF 
patients  shows a significant difference between all three values (p value 
0.000). 
There was significant difference in the pattern of values in diabetics ( p 
value  0.001) and when comparing the age groups ( p value  0.004). 
Patients with wound infection showed significant difference in the pattern of  
values but was not statistically significant   ( p value  0.077). 
HT and gender did not reveal any significant difference in the pattern of 
values. 
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Analysis of transferrin in PLIF group 
          The transferrin values at pre op , post op and follow up of the PLIF 
patients shows a significant difference between all three values (p value 
0.000). 
There was significant difference in the pattern of values in  diabetics ( p 
value 0.000), when comparing between the age groups ( p value 0.012) and 
in patients with wound infection ( p value – 0.033). 
HT and gender did not reveal any significant difference in the pattern of 
values. 
 
Complications  
Wound infection – 3 pts. (9.1 % ).   
2 were deep infection  and 1 superficial infection. 
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Graphs for analysis of prealbumin in PLIF group ( Tables 1,2) 
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Graphs for analysis of prealbumin in PLIF group( Tables 3,4) 
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Graphs for analysis of prealbumin in PLIF group( Tables 5,6) 
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Graphs for analysis of transferrin in PLIF group( Tables 7,8) 
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Graphs for analysis of transferrin in PLIF group( Tables 9.10) 
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Graphs for analysis of transferrin in PLIF group( Tables 11,12) 
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Infective Spondylitis 
The number of patients followed up  - 18 
Age                                                      – 16 to 72 yrs. 
Average age                                         – 40.55 yrs. 
< 40 yrs age group                                – 11 pts. ( 61.1%) 
Females                                                 – 5 pts.(27.8% ) 
Males                                                     – 13 pts.(72.2%) 
The Number of paraplegics                   – 10 pts.( 55.56%) 
 
Comorbidities 
DM – 4 pts. (22.2 %) 
HT  – 3pts.  (16.7 %) 
 
BMI 
BMI < 20 – 2 pts.  (11.1 %) 
BMI > 25 – 2 pts. ( 11.1%) 
There was no association of BMI with the incidence of  UTI and wound 
infection.( Annexure – tables 93 to 96). 
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Analysis of  prealbumin in Infective Spondylitis  group 
          The prealbumin values at pre op , post op and follow up of the 
infective spondylitis patients shows a significant difference  between all 
three values (p value  0.000). 
No statistically significant difference was observed in the pattern of 
prealbumin values  between the variables for comparison ( age group, 
gender, DM, HT). 
Patients with wound infection showed significant difference in the pattern of 
values but was not statistically significant  ( p value  0.147). 
 
Analysis of  transferrin in Infective Spondylitis  group 
          The transferrin values at pre op , post op and follow up of the infective 
spondylitis patients shows a significant difference between all three values 
(p value  0.000). 
No statistically significant difference was observed in the pattern of  
transferrin values between the variables for comparison ( age group, gender, 
DM, HT). 
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Complications  
Wound infection – 2 pts. ( 11.1 % ) 
Both were  superficial infection. 
UTI –8 pts.( 44.4 % )  
 All the patients with UTI were on CBD.6 out of 8patients with UTI were 
paraplegic ( 75%). 
6 out of 10 paraplegics had UTI – 60 %. 
 
 
Comparison beween PLIF group and Infective Spondylitis group 
          The pattern of prealbumin values showed a significant difference ( p 
value  0.032) between the two groups. The pattern of transferrin values 
showed a difference which was not statistically significant( p value  0.2). 
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Graphs for analysis of prealbumin in Inf. Spond ( Tables 13,14) 
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Graphs for analysis of prealbumin in Inf. Spond ( Tables 15,16) 
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Graphs for analysis of prealbumin in Inf. Spond ( Tables 17,18) 
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Graphs for analysis of prealbumin in Inf. Spond ( Table 19) 
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Graphs for analysis of transferrin in Inf. Spond ( Tables 20,21) 
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Graphs for analysis of transferrin in Inf. Spond ( Tables 22,23) 
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Graphs for analysis of transferrin in Inf. Spond ( Tables 24,25) 
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Graphs for analysis of transferrin in Inf. Spond ( Table 26) 
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Graphs for comparison between PLIF group and Infective Spondylitis 
group  ( Tables 27,28) 
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Unilateral replacement 
 
The number of patients followed up – 46. 
Age                                                     – 21 to 76 yrs. 
Average age                                        – 49.30 yrs. 
Age > 40 yrs                                        – 36 pts.(78.3 %) 
Males                                                     -21 pts.(45.7% ) 
Females                                                – 25 pts.(54.3%) 
 
Comorbidities 
DM – 6 pts.(13 %) 
HT – 8 pts.( 17.4%) 
 
BMI 
BMI < 20 – 1pts. ( 2.1 %) 
BMI > 25 – 18 pts. (39.13 %) 
There was no association of BMI with the incidence of UTI and wound 
infection. 
 
 
 
51 
 
Analysis of  prealbumin in Unilateral Replacement  group 
           The prealbumin values at pre op , post op and follow up of the 
unilateral replacement patients shows a significant difference between all 
three values (p value 0.000). 
No statistically significant difference was observed in the pattern of 
prealbumin values between the variables for comparison (  gender, DM, HT) 
except when comparing age groups (p value  0.000). 
 
Analysis of  transferrin in Unilateral Replacement  group 
          The transferrin values at pre op , post op and follow up of the 
unilateral replacement patients shows a significant difference between all 
three values (p value  0.000). 
No statistically significant difference was observed in the pattern of  
transferrin values between the variables for comparison (  gender, DM, HT) 
except when comparing age groups (p value  0.000). 
 
Complications 
Wound infection – 8 pts ( 17.4%). 
6 ot them were superficial infection (13%) and 2 were deep infection(4.4%). 
UTI – 1pt (2.1%) ; it was catheter related UTI. 
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Graphs for analysis of prealbumin in Unilat replacement( Table 29) 
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Graphs for analysis of prealbumin in Unilat replacement( Tables 30,31) 
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Graphs for analysis of prealbumin in Unilat replacement( Tables 32,33) 
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Graphs for analysis of transferrin in Unilat replacement( Table 34) 
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Graphs for analysis of transferrin in Unilat replacement( Tables 35,36) 
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Graphs for analysis of transferrin in Unilat replacement( Tables 37,38) 
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Bilateral Replacement 
The Number of  patients followed up  – 16. 
Age                                                        – 30 to 72 yrs. 
Avg age                                                  – 53.5 yrs. 
Age > 40 yrs                                           – 15 pts.(93.75 %) 
Males                                                       – 6 pts.(37.5%) 
Females                                                   – 10 pts.(62.5 %) 
 
Comorbidities 
DM- 3pts.  (18.75 %) 
HT - 4 pts. ( 25%) 
 
BMI 
BMI < 20 – nil. 
BMI > 25 – 5pts. ( 31.25%) 
There was no association of BMI with the incidence of UTI and wound 
infection. 
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Analysis of prealbumin in Bilateral replacement group 
          The prealbumin values at pre op , post op and follow up of the 
bilateral replacement patients shows a significant difference between all 
three values (p value  0.000). 
No statistically significant difference was observed in the pattern of 
prealbumin values between the variables for comparison( age group, gender, 
HT)except in diabetics (p value 0.006). 
Analysis of transferrin in Bilateral replacement group 
          The transferrin values at pre op , post op and follow up of the bilateral 
replacement patients shows a significant difference between all three values 
(p value  0.000). 
No statistically significant difference was observed in the pattern of 
transferrin values between the variables for comparison ( age group, gender, 
DM, HT). 
Comparison between Unilateral and Bilateral replacement groups 
Pre albumin values showed a significant difference ( p value  0.016) between 
the two groups .Transferrin values showed a difference which was not 
statistically significant ( p value  0.077) 
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Graphs for analysis of prealbumin in Bilat replacement ( Table 39) 
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Graphs for analysis of prealbumin in Bilat replacement ( Tables 40,41) 
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Graphs for analysis of prealbumin in Bilat replacement ( Tables 42,43) 
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Graphs for analysis of transferrin in Bilat replacement ( Table 44) 
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Graphs for analysis of transferrin in Bilat replacement ( Tables 45,46) 
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Graphs for analysis of transferrin in Bilat replacement ( Tables 47,48) 
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Graphs for comparison between Unilateral and Bilateral replacement 
groups  ( Tables 49,50) 
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Unilateral TKR 
 
The number of patients followed up  – 15. 
Age                                                     – 30 to 76 yrs. 
Avg age                                               – 52.9 yrs. 
> 40 yrs age group                               – 14 pts.(93.3%) 
Females                                                – 9 pts.(60% ) 
Males                                                    –6 pts.( 40%) 
 
Comorbidities 
DM –4  pts.(26.7 %) 
HT – 3 pts. (20%) 
 
BMI 
BMI < 20 – nil. 
BMI > 25 -  10 pts.  (57.8%) 
There was no association of BMI with the incidence of  wound infection.     
 ( Annexure – tables 97,98) 
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Analysis of prealbumin in Unilateral TKR group 
          The prealbumin values at pre op , post op and follow up of the 
unilateral TKR patients shows a significant difference between all three 
values (p value 0.000). 
No statistically significant difference was observed in the pattern of 
prealbumin values between the variables for comparison ( age group, 
gender, DM, HT). 
 
Analysis of transferrin in Unilateral TKR group 
          The transferrin values at pre op , post op and follow up of the 
unilateral TKR patients shows a significant difference between all three 
values (p value 0.000). 
No statistically significant difference was observed in the pattern of 
transferrin values between the variables for comparison ( age group, gender, 
DM, HT). 
Complications  
Wound infection –  3pts. ( 20% ). 
All of them were superficial infection. 
UTI –1pt. (6.7 % ); It was catheter related UTI. 
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Graphs for analysis of prealbumin in Unilateral TKR (Tables 51,52) 
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  Graphs for analysis of prealbumin in Unilateral TKR(Tables 53,54) 
 
 
 
 
 
 
71 
 
  Graphs for analysis of prealbumin in Unilateral TKR(Tables 55,56) 
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Graphs for analysis of transferrin in Unilateral TKR (Tables 57,58) 
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Graphs for analysis of transferrin in Unilateral TKR (Tables 59,60) 
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Graphs for analysis of transferrin in Unilateral TKR (Tables 61,62) 
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Bilateral TKR 
 
The number of patients followed up  – 11. 
Age                                                     – 30 to 72 yrs. 
Avg age                                              – 54.45 yrs. 
> 40 yrs age group                             – 10 pts.(90.9%) 
Females                                              – 9 pts.(81.8%)  
Males                                                  – 2 pts.(18.2%) 
 
Comorbidities 
DM –  3 pts.(27.3 %) 
HT   – 3 pts.(27.3 %) 
RA   – 3 pts.(27.3 %) 
 
BMI 
BMI < 20 – nil. 
BMI > 25 -  5 pts (45.5%) 
No association of  BMI with UTI or wound infection. ( Annexure – tables 99 
to 102 ). 
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Analysis of prealbumin in Bilateral TKR group 
          The prealbumin values at pre op , post op and follow up of the 
bilateral TKR patients shows a significant difference between all three 
values (p value 0.000). 
No statistically significant difference was observed in the pattern of 
prealbumin values  between the variables for comparison ( age group, 
gender, HT) except in diabetics ( p value 0.02). 
Analysis of transferrin in Bilateral TKR group 
          The transferrin values at pre op , post op and follow up of the bilateral 
TKR patients shows a significant difference between all three values (p 
value 0.000). 
No statistically significant difference was observed in the pattern of 
transferrin values  between the variables for comparison ( age group, gender, 
DM, HT). 
Complications  
Wound infection –  1 pt. ( 9.1%) ; It was a superficial infection. 
UTI – 1 pt. (9.1 % ); It was a catheter related UTI. 
Wound infection have a tendency to occur in overweight ( p value 0.145 ). 
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Comparison  between Unilateral and Bilateral TKR groups. 
Both prealbumin and transferrin values shows no statistically significant 
difference between the Unilateral and Bilateral TKR groups in the pattern of 
prealbumin and transferrin values. 
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Graphs for Analysis of prealbumin in Bilateral TKR (Tables 63,64) 
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Graphs for Analysis of prealbumin in Bilateral TKR (Tables 65,66) 
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Graphs for Analysis of prealbumin in Bilateral TKR (Tables 67,68) 
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Graphs for analysis of transferrin in Bilateral TKR (Tables 69,70) 
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Graphs for analysis of transferrin in Bilateral TKR (Tables 71,72) 
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Graphs for analysis of transferrin in Bilateral TKR (Tables 73,74) 
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Graphs for comparison of Unilateral and Bilateral TKR (Tables 75,76) 
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Unilateral THR 
 
The number of patients followed up  – 31. 
Age                                                      – 21 to 74 yrs. 
Avg age                                               – 47.54 yrs. 
> 40 yrs age group                               –21pts. ( 67.7%) 
Females                                                – 11 pts.(35.5%) 
Males                                                   – 20 pts. (64.5%) 
 
Comorbidities 
DM – 2 pts. (6.5 %) 
HT  – 5 pts.  (16.12%) 
 
BMI 
BMI < 20 – 1 pt ( 3.2 %). 
BMI > 25 -  8 pts. (26.9%). 
No assocation of BMI with incidence of  wound infection. 
( Annexure – tables 103,104). 
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Analysis of prealbumin in Unilateral THR group. 
          The prealbumin values at pre op , post op and follow up of the 
unilateral THR patients shows a significant difference between all three 
values (p value 0.000). 
 Statistically significant difference was observed in the pattern of prealbumin 
values in hypertensives (p value  0.014)and when comparing the age groups 
(p value 0.000). 
Patients with wound infection showed significant difference in the pattern of  
values but was not statistically significant  ( p value – 0.154). 
 
Analysis of transferrin in Unilateral THR group. 
          The transferrin values at pre op , post op and follow up of the 
unilateral THR patients shows a significant difference between all three 
values (p value 0.000). 
Statistically significant difference was observed in the pattern of  transferrin 
values in hypertensives (p value 0.009) and when comparing the age groups 
(p value 0.000). 
Patients with wound infection showed significant difference in the pattern of 
values but was not statistically significant  ( p value – 0.171). 
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Complications  
Wound infection –  4  pts.(16.2%). 
2 of them were deep infection  and 2 superficial infection . 
 
Comparison between unilateral TKR and THR 
There was no statistically significant difference between the groups in the 
pattern of  both Prealbumin and Transferrin values. 
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Graphs for analysis of prealbumin in unilateral THR (Tables 77,78) 
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Graphs for analysis of prealbumin in unilateral THR (Tables 79,80) 
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Graphs for analysis of prealbumin in unilateral THR (Tables 81,82) 
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Graphs for analysis of transferrin in Unilateral THR (Tables 83,84) 
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Graphs for analysis of transferrin in Unilateral THR (Tables 85,86) 
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Graphs for analysis of transferrin in Unilateral THR (Tables 87,88) 
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Graphs for comparison of Unilateral THR and TKR (Tables 89,90) 
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DISCUSSION 
          This prospective study was designed to analyze the effect of major 
orthopaedic surgery on the nutritional status of the patients. The results of 
the study shows significant difference in the pre op, post op and the follow 
up values of biochemical marker – Prealbumin and transferrin, in all groups 
of patients. This indicate that the trauma of hospitalisation , surgery and 
anaesthesia does affect the nutritional status of the patient, as described in 
various other studies10-14. 
          The incidence of undernutrition  in  this study was found  to be  
4.42%, where as the literature quotes values  around  40% in orthopaedic 
inpatients 37-41. This may be due to the patient selection criteria. We included 
only those patients who were undergoing planned elective major orthopaedic 
surgery. We excluded the patients admitted for surgery for trauma and 
tumours. More over many of them were overnourished ( BMI > 25 – 
33.62%). Most of the literature on malnutrition in orthopaedics are on 
trauma , especially hip trauma in the elderly42-45. These might be reasons for 
the gross difference in the incidence of malnutrition in our study. 
          The biochemical parameters, even though are much better at follow up 
compared to the post op level, do not come back to the pre op level even at 3 
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months. This indicate that these patients need to be followed up further to 
know when actually the parameters come back to the pre op level. 
            Diabetes and age > 40 yrs are the two important factors that affect 
the nutritional recovery of the patients undergoing major orthopaedic trauma 
in our study. The relationship between age and the nutritional status in 
orthopaedic patients have been extensively studied especially in hip fractures 
in elderly42-45. 
           PLIF patients tend to behave significantly different in their nutritional 
status compared to Infective Spondylitis patients. This  may be due to the 
effect of infection, often chronic diseases like tuberculosis, on the nutritional 
status and parameters. Unilateral replacement patients  as a whole also tend 
to behave differently compared to their bilateral counter parts. 
          There were no difference in the behaviour of nutritional parameters 
between unilateral and bilateral TKR patients. There were no difference in 
the behaviour of nutritional parameters between unilateral THR and TKR 
patients.In bilateral TKR patients , over weight patients were predisposed to 
wound infection. 
          Only in unilateral THR patients, hyperrtension gains significance as a 
factor affecting the pattern of changes in the nutritional marker levels.A 
presumed cause offered can be related to the blood loss during surgery. 
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                    The wound infections in the patients in our study did not 
correlate with their nutritional status even though literature quotes positive 
correlation between the two62-67. This may be due to the fact that 
undernutrtion was detected only in 4.42% of the study population. 
          The incidence of UTI was found to be correlating with presence of 
urinary catheter and parplegics in infective spondylitis group. 
          In our study , Prealbumin correlate with the nutritional status better 
than transferrin. Even though studies have shown the effectiveness of 
transferrin as a nutritional marker52, Prealbumin may be a better marker for 
the nutritional assessment. 
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CONCLUSION 
          This prospective study clearly shows the effects of  major elective 
orthopaedic surgery on the nutritional status of the patients. The three 
important conclusions of our study are – 
1. Age > 40is the main patient related factor that affect the nutritional 
status of patients undergoing major elective orthopaedic surgery. 
2. Among the comorbidities, diabetes mellitus  affects the nutrtional 
status of the patients undergoing major elective orthopaedic surgery. 
3. This study also shows the effectiveness of prealbumin as a reliable 
nutritional marker. Prealbumin can be used routinely in patients at risk 
of malnutrition to assess and to take appropriate nutritional measures 
toprevent complications. 
4. Possibly prealbumin is a better indicator of nutritional status than 
transferrin. 
 
 
 
 
 
 
99 
 
 
LIMITATIONS OF THE STUDY 
1.Small sample size – Since the incidence of malnutrition in our study was 
only 4.42% compared to 40% in the literature, a bigger sample size would 
have given a better and clearer picture . 
2. Short follow up -  At 3 months follow up , the biochemical parameters had 
not come back to pre op level. So a longer follow up would have possibly 
shown the time taken for the parameters to normalize after surgery. 
3. Patient selection – We did not include trauma and tumour patients in our 
study . These  patient groups are more vulnerable to nutritional depletion and 
a similar study on those patient groups would  be valuable. 
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                         Proforma 
 
Name : 
Age : 
Sex : 
Hosp.No: 
Occupation: 
Address : 
 
 
Diagnosis: 
 
Surgery done : 
 
Comorbidities :  
 
 
Type of anaesthesia : 
Duration of surgery : 
Duration of anaesthesia: 
Total blood loss: 
Transfusions: 
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Anthropometry:   
               At adm         At dis           3m           6m 
BMI 
MUAC 
TSF 
 
Hematology  
                     At adm         At dis           3m           6m 
PCV 
TLC 
Alb 
Pre alb 
Transferrin   
 
 
                       Informed Consent 
i) I confirm that I have read and understood the 
information sheet dated _________ for the above 
study and have had the opportunity to ask questions.  
 
(ii) I understand that my participation in the study is 
voluntary and that I am 
113 
 
free to withdraw at any time, without giving any 
reason, without my medical care or legal rights being 
affected.  
 (iii) I understand that the Sponsor of the clinical trial, 
others working on the Sponsor’s behalf, the Ethics 
Committee and the regulatory authorities will not 
need my permission to look at my health records both 
in respect of the current study and any further 
research that may be conducted in relation to it, even 
if I withdraw from the trial. I agree to this access. 
However, I understand that my identity will not be 
revealed in any information released to third parties 
or published. 
 
(iv) I agree not to restrict the use of any data or 
results that arise from this study provided such a use 
is only for scientific purpose(s)  
 
(v) I agree to take part in the above study.  
 
Consent taken by -    
                                                         patient/guardian 
 
 
                                                          witness 
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ANNEXURE 
Tables for analysis of prealbumin in PLIF group 
Table - 1 
(I) PA (J) PA 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 3.364* .178 .000 2.913 3.815 
3 .667* .135 .000 .325 1.009 
2 1 -3.364* .178 .000 -3.815 -2.913 
3 -2.697* .127 .000 -3.017 -2.377 
3 1 -.667* .135 .000 -1.009 -.325 
2 2.697* .127 .000 2.377 3.017 
 
 
 
 
 
 
Table - 2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 31783.440 1 31783.440 1.838E3 .000 
age_rec 163.198 1 163.198 9.439 .004 
Error 535.974 31 17.289   
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Tables for analysis of prealbumin in PLIF group 
Table - 3 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 65164.070 1 65164.070 2.890E3 .000 
gender .070 1 .070 .003 .956 
Error 699.102 31 22.552   
 
 
 
 
 
 
 
 
 
 
 
Table - 4 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 45645.655 1 45645.655 2.987E3 .000 
DM 225.493 1 225.493 14.757 .001 
Error 473.678 31 15.280   
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Tables for analysis of prealbumin in PLIF group 
Table - 5 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 27838.245 1 27838.245 1.244E3 .000 
HT 5.356 1 5.356 .239 .628 
Error 693.816 31 22.381   
 
 
 
 
 
 
 
 
 
 
Table - 6 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 20092.525 1 20092.525 987.287 .000 
woundinf 68.283 1 68.283 3.355 .077 
Error 630.889 31 20.351   
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Tables for analysis of transferrin in PLIF group 
Table - 7 
(I) TF (J) TF 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 23.485* 1.823 .000 18.880 28.090 
3 3.303* 1.084 .014 .564 6.042 
2 1 -23.485* 1.823 .000 -28.090 -18.880 
3 -20.182* 1.452 .000 -23.851 -16.513 
3 1 -3.303* 1.084 .014 -6.042 -.564 
2 20.182* 1.452 .000 16.513 23.851 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 8 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3390385.092 1 3390385.092 1.887E3 .000 
age_rec 12909.698 1 12909.698 7.185 .012 
Error 55700.322 31 1796.785   
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Tables for analysis of transferrin in PLIF group 
Table - 9 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 7068118.968 1 7068118.968 3.194E3 .000 
gender 18.927 1 18.927 .009 .927 
Error 68591.093 31 2212.616   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 10 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 4938701.680 1 4938701.680 3.559E3 .000 
DM 25586.367 1 25586.367 18.436 .000 
Error 43023.653 31 1387.860   
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Tables for analysis of transferrin in PLIF group 
Table - 11 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3025347.965 1 3025347.965 1.376E3 .000 
HT 438.874 1 438.874 .200 .658 
Error 68171.147 31 2199.069   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 12 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2150496.849 1 2150496.849 1.127E3 .000 
woundinf 9464.365 1 9464.365 4.961 .033 
Error 59145.656 31 1907.924   
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Tables for analysis of prealbumin in Infective Spondylitis group 
 
Table - 13 
 
(I) PA (J) PA 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 3.167* .232 .000 2.550 3.783 
3 .500 .271 .248 -.220 1.220 
2 1 -3.167* .232 .000 -3.783 -2.550 
3 -2.667* .243 .000 -3.311 -2.023 
3 1 -.500 .271 .248 -1.220 .220 
2 2.667* .243 .000 2.023 3.311 
 
 
 
 
 
 
 
 
 
Table - 14 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 29541.339 1 29541.339 1.195E3 .000 
age_rec 32.747 1 32.747 1.325 .267 
Error 395.420 16 24.714   
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Tables for analysis of prealbumin in Infective Spondylitis group 
 
Table - 15 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 25200.577 1 25200.577 942.982 .000 
gender .577 1 .577 .022 .885 
Error 427.590 16 26.724   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 16 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 21642.890 1 21642.890 810.591 .000 
DM .964 1 .964 .036 .852 
Error 427.202 16 26.700   
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Tables for analysis of prealbumin in Infective Spondylitis group 
 
Table - 17 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 16598.848 1 16598.848 663.733 .000 
HT 28.033 1 28.033 1.121 .305 
Error 400.133 16 25.008   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 18 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 30912.300 1 30912.300 1.262E3 .000 
UTI 36.300 1 36.300 1.482 .241 
Error 391.867 16 24.492   
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Tables for analysis of prealbumin in Infective Spondylitis group 
 
 
Table -19 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 11213.891 1 11213.891 479.765 .000 
woundinf 54.188 1 54.188 2.318 .147 
Error 373.979 16 23.374   
 
  
124 
 
Tables for analysis of transferrin in Infective Spondylitis group 
 
Table - 20 
 
(I) TF (J) TF 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 22.056* 1.697 .000 17.551 26.560 
3 4.444* 1.469 .023 .544 8.345 
2 1 -22.056* 1.697 .000 -26.560 -17.551 
3 -17.611* 2.144 .000 -23.303 -11.919 
3 1 -4.444* 1.469 .023 -8.345 -.544 
2 17.611* 2.144 .000 11.919 23.303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 21 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3494964.262 1 3494964.262 5.187E3 .000 
age_rec 220.262 1 220.262 .327 .575 
Error 10779.905 16 673.744   
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Tables for analysis of transferring in Infective spondylitis group. 
 
Table - 22 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2928351.193 1 2928351.193 4.441E3 .000 
gender 450.156 1 450.156 .683 .421 
Error 10550.010 16 659.376   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 23 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2607619.048 1 2607619.048 4.178E3 .000 
DM 1015.048 1 1015.048 1.626 .220 
Error 9985.119 16 624.070   
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Tables for analysis of transferring in Infective spondylitis group 
 
Table - 24 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2036849.633 1 2036849.633 2.975E3 .000 
HT 45.633 1 45.633 .067 .800 
Error 10954.533 16 684.658   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 25 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3639502.801 1 3639502.801 5.347E3 .000 
UTI 110.208 1 110.208 .162 .693 
Error 10889.958 16 680.622   
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Tables for analysis of transferring in Infective spondylitis group 
 
Table - 26 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1480167.521 1 1480167.521 2.181E3 .000 
woundinf 143.521 1 143.521 .212 .652 
Error 10856.646 16 678.540   
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Tables for comparison between PLIF group and Infective Spondylitis 
group 
 
Table - 27 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 87794.675 1 87794.675 3.816E3 .000 
Group 112.322 1 112.322 4.882 .032 
Error 1127.338 49 23.007   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 28 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 9875864.728 1 9875864.728 6.079E3 .000 
Group 2745.120 1 2745.120 1.690 .200 
Error 79610.187 49 1624.698   
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Tables for analysis of prealbumin in Unilateral replacement group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 29 
 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 80811.700 1 80811.700 4.368E3 .000 
age_rec 376.917 1 376.917 20.373 .000 
Error 814.017 44 18.500   
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Tables for analysis of prealbumin in Unilateral replacement group 
 
Table – 30 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 101632.664 1 101632.664 3.762E3 .000 
gender 2.230 1 2.230 .083 .775 
Error 1188.705 44 27.016   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 31 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 44188.452 1 44188.452 1.736E3 .000 
DM 71.235 1 71.235 2.799 .101 
Error 1119.700 44 25.448   
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Tables for analysis of prealbumin in Unilateral replacement group 
 
Table – 32 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 56626.325 1 56626.325 2.232E3 .000 
HT 74.847 1 74.847 2.951 .093 
Error 1116.088 44 25.366   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 33 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 56905.502 1 56905.502 2.214E3 .000 
woundinf 60.110 1 60.110 2.339 .133 
Error 1130.825 44 25.701   
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Tables for analysis of transferrin in Unilateral replacement group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 34 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 8003781.875 1 8003781.875 4.847E3 .000 
age_rec 24386.223 1 24386.223 14.767 .000 
Error 72662.277 44 1651.415   
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Tables for analysis of transferrin in Unilateral replacement group 
 
Table – 35 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1.020E7 1 1.020E7 4.623E3 .000 
gender .472 1 .472 .000 .988 
Error 97048.028 44 2205.637   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 36 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 4506460.132 1 4506460.132 2.130E3 .000 
DM 3961.175 1 3961.175 1.872 .178 
Error 93087.325 44 2115.621   
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Tables for analysis of transferrin in Unilateral replacement group 
 
Table – 37 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 5714800.953 1 5714800.953 2.765E3 .000 
HT 6108.316 1 6108.316 2.955 .093 
Error 90940.184 44 2066.822   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 38 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 5730918.881 1 5730918.881 2.749E3 .000 
woundinf 5327.577 1 5327.577 2.556 .117 
Error 91720.923 44 2084.566   
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Tables for analysis of prealbumin in bilateral replacement group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 39 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 7501.356 1 7501.356 614.226 .000 
age_rec 2.939 1 2.939 .241 .631 
Error 170.978 14 12.213   
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Tables for analysis of prealbumin in bilateral replacement group 
 
Table – 40 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 28905.339 1 28905.339 2.336E3 .000 
gender .672 1 .672 .054 .819 
Error 173.244 14 12.375   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 41 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 17380.137 1 17380.137 2.453E3 .000 
DM 74.720 1 74.720 10.546 .006 
Error 99.197 14 7.085   
 
 
 
 
 
137 
 
 
Tables for analysis of prealbumin in biilateral replacement group 
 
Table – 42 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 22750.694 1 22750.694 1.920E3 .000 
HT 8.028 1 8.028 .677 .424 
Error 165.889 14 11.849   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 43 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 14040.429 1 14040.429 1.190E3 .000 
woundinf 8.679 1 8.679 .735 .406 
Error 165.238 14 11.803   
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Tables for analysis of transferrin in Bilateral replacement group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 44 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 757123.756 1 757123.756 450.645 .000 
age_rec 22.756 1 22.756 .014 .909 
Error 23521.244 14 1680.089   
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Tables for analysis of transferrin in Bilateral replacement group 
 
Table – 45 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3037841.422 1 3037841.422 1.847E3 .000 
gender 513.422 1 513.422 .312 .585 
Error 23030.578 14 1645.041   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 46 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1879480.692 1 1879480.692 1.337E3 .000 
DM 3859.692 1 3859.692 2.745 .120 
Error 19684.308 14 1406.022   
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Tables for analysis of transferrin in Bilateral replacement group 
 
Table – 47 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2416988.444 1 2416988.444 1.459E3 .000 
HT 348.444 1 348.444 .210 .654 
Error 23195.556 14 1656.825   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 48 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1498137.190 1 1498137.190 953.311 .000 
woundinf 1542.857 1 1542.857 .982 .339 
Error 22001.143 14 1571.510   
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Tables for comparison between Unilateral and Bilateral replacement 
groups 
 
Table – 49 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 99020.272 1 99020.272 4.353E3 .000 
Group 139.627 1 139.627 6.138 .016 
Error 1364.851 60 22.748   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 50 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1.019E7 1 1.019E7 5.068E3 .000 
Group 6490.452 1 6490.452 3.229 .077 
Error 120592.500 60 2009.875   
 
142 
 
Tables for analysis of prealbumin in Unilateral TKR 
 
Table – 51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 52 
 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 7936.025 1 7936.025 332.495 .000
age_rec .025 1 .025 .001 .974
Error 310.286 13 23.868   
 
 
     
(I) PA (J) PA 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 3.800* .243 .000 3.140 4.460 
3 .867* .165 .000 .418 1.316 
2 1 -3.800* .243 .000 -4.460 -3.140 
3 -2.933* .284 .000 -3.705 -2.162 
3 1 -.867* .165 .000 -1.316 -.418 
2 2.933* .284 .000 2.162 3.705 
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Tables for analysis of prealbumin in Unilateral TKR 
 
Table – 53 
 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 30379.615 1 30379.615 1.288E3 .000
Gender 3.793 1 3.793 .161 .695
Error 306.519 13 23.578   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 54 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 24080.316 1 24080.316 1.112E3 .000 
DM 28.849 1 28.849 1.332 .269 
Error 281.462 13 21.651   
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Tables for analysis of prealbumin in Unilateral TKR 
 
Table – 55 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 20844.272 1 20844.272 897.683 .000 
HT 8.450 1 8.450 .364 .557 
Error 301.861 13 23.220   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 56 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 19950.139 1 19950.139 850.411 .000 
woundinf 5.339 1 5.339 .228 .641 
Error 304.972 13 23.459   
 
 
145 
 
Tables for analysis of transferrin in Unilateral TKR group 
 
Table – 57 
 
(I) TF (J) TF 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 32.909* 4.111 .000 21.111 44.708 
3 6.000* 2.036 .044 .156 11.844 
2 1 -32.909* 4.111 .000 -44.708 -21.111 
3 -26.909* 3.701 .000 -37.532 -16.286 
3 1 -6.000* 2.036 .044 -11.844 -.156 
2 26.909* 3.701 .000 16.286 37.532 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 58 
 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 809869.435 1 809869.435 410.559 .000
age_rec 13.435 1 13.435 .007 .935
Error 25643.810 13 1972.601   
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Tables for analysis of transferrin in Unilateral TKR 
 
Table – 59 
 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 3092942.237 1 3092942.237 1.577E3 .000
Gender 157.170 1 157.170 .080 .782
Error 25500.074 13 1961.544   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 60 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2489760.073 1 2489760.073 1.294E3 .000 
DM 647.184 1 647.184 .336 .572 
Error 25010.061 13 1923.851   
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Tables for analysis of transferrin in Unilateral TKR 
 
Table – 61 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2127693.889 1 2127693.889 1.130E3 .000 
HT 1185.800 1 1185.800 .630 .442 
Error 24471.444 13 1882.419   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 62 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 2016971.756 1 2016971.756 1.058E3 .000 
woundinf 880.022 1 880.022 .462 .509 
Error 24777.222 13 1905.940   
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Tables for analysis of prealbumin in Bilateral TKR group 
 
Table – 63 
 
(I) PA (J) PA 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 3.545* .282 .000 2.737 4.354 
3 .455 .207 .159 -.140 1.050 
2 1 -3.545* .282 .000 -4.354 -2.737 
3 -3.091* .211 .000 -3.697 -2.485 
3 1 -.455 .207 .159 -1.050 .140 
2 3.091* .211 .000 2.485 3.697 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 64 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 7130.776 1 7130.776 546.342 .000 
age_rec 6.412 1 6.412 .491 .501 
Error 117.467 9 13.052   
 
 
149 
 
Tables for analysis of prealbumin in Bilateral TKR group 
 
Table – 65 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 11858.108 1 11858.108 908.997 .000 
gender 6.471 1 6.471 .496 .499 
Error 117.407 9 13.045   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 66 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 15414.187 1 15414.187 2.100E3 .000 
DM 57.823 1 57.823 7.878 .020 
Error 66.056 9 7.340   
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Tables for analysis of prealbumin in Bilateral TKR group 
 
Table – 67 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 15858.505 1 15858.505 1.295E3 .000 
HT 13.657 1 13.657 1.115 .318 
Error 110.222 9 12.247   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 68 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 6718.548 1 6718.548 489.083 .000 
woundinf .245 1 .245 .018 .897 
Error 123.633 9 13.737   
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Table for analysis of transferrin in bilateral TKR group 
 
Table – 69 
     
(I) TF (J) TF 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 32.909* 4.111 .000 21.111 44.708 
3 6.000* 2.036 .044 .156 11.844 
2 1 -32.909* 4.111 .000 -44.708 -21.111 
3 -26.909* 3.701 .000 -37.532 -16.286 
3 1 -6.000* 2.036 .044 -11.844 -.156 
2 26.909* 3.701 .000 16.286 37.532 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 70 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 720908.412 1 720908.412 332.531 .000 
age_rec 9.503 1 9.503 .004 .949 
Error 19511.467 9 2167.941   
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Table for analysis of transferrin in bilateral TKR group 
 
Table – 71 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1226909.118 1 1226909.118 628.402 .000 
gender 1949.118 1 1949.118 .998 .344 
Error 17571.852 9 1952.428   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 72 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1660451.636 1 1660451.636 879.615 .000 
DM 2531.636 1 2531.636 1.341 .277 
Error 16989.333 9 1887.704   
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Table for analysis of transferrin in bilateral TKR group 
 
Table – 73 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1703771.157 1 1703771.157 792.996 .000 
HT 184.247 1 184.247 .086 .776 
Error 19336.722 9 2148.525   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 74 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 722592.012 1 722592.012 333.461 .000 
woundinf 18.436 1 18.436 .009 .929 
Error 19502.533 9 2166.948   
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Tables for comparison between Unilateral and Bilateral TKR groups 
 
Table – 75 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 50528.438 1 50528.438 2.793E3 .000 
Group 51.105 1 51.105 2.825 .106 
Error 434.190 24 18.091   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 76 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 5232665.273 1 5232665.273 2.780E3 .000 
Group 2585.068 1 2585.068 1.373 .253 
Error 45178.214 24 1882.426   
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Tables for analysis of prealbumin in unilateral THR group 
 
Table – 77 
     
(I) PA (J) PA 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 3.548* .190 .000 3.066 4.031 
3 1.032* .118 .000 .733 1.332 
2 1 -3.548* .190 .000 -4.031 -3.066 
3 -2.516* .179 .000 -2.970 -2.063 
3 1 -1.032* .118 .000 -1.332 -.733 
2 2.516* .179 .000 2.063 2.970 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 78 
 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 66028.065 1 66028.065 4.175E3 .000 
age_rec 381.613 1 381.613 24.128 .000 
Error 458.667 29 15.816   
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Tables for analysis of prealbumin in unilateral THR group 
 
Table – 79 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 65841.164 1 65841.164 2.287E3 .000 
gender 5.551 1 5.551 .193 .664 
Error 834.729 29 28.784   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 80 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 16276.770 1 16276.770 574.900 .000
DM 19.222 1 19.222 .679 .417
Error 821.057 29 28.312   
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Tables for analysis of prealbumin in unilateral THR group 
 
Table – 81 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 35393.763 1 35393.763 1.510E3 .000 
HT 160.731 1 160.731 6.859 .014 
Error 679.549 29 23.433   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 82 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 36699.098 1 36699.098 1.360E3 .000 
woundinf 57.808 1 57.808 2.142 .154 
Error 782.472 29 26.982   
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Tables for analysis of transferrin in Unilateral THR group 
 
Table – 83 
 
(I) TF (J) TF 
Mean Difference 
(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 35.226* 1.918 .000 30.362 40.090 
3 11.581* 1.760 .000 7.119 16.043 
2 1 -35.226* 1.918 .000 -40.090 -30.362 
3 -23.645* 1.786 .000 -28.173 -19.117 
3 1 -11.581* 1.760 .000 -16.043 -7.119 
2 23.645* 1.786 .000 19.117 28.173 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 6525440.865 1 6525440.865 4.265E3 .000 
age_rec 24445.597 1 24445.597 15.978 .000 
Error 44369.651 29 1529.988   
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Tables for analysis of transferrin in Unilateral THR group 
 
Table – 85 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 6549969.205 1 6549969.205 2.761E3 .000 
gender 25.549 1 25.549 .011 .918 
Error 68789.698 29 2372.059   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 86 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1613671.416 1 1613671.416 705.031 .000 
DM 2440.190 1 2440.190 1.066 .310 
Error 66375.057 29 2288.795   
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Tables for analysis of transferrin in Unilateral THR group 
 
Table – 87 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3550095.279 1 3550095.279 1.901E3 .000 
HT 14668.527 1 14668.527 7.856 .009 
Error 54146.721 29 1867.128   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 88 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 3691825.296 1 3691825.296 1.661E3 .000 
woundinf 4374.027 1 4374.027 1.968 .171 
Error 64441.221 29 2222.111   
 
161 
 
Tables for comparison between Unilateral THR and TKR groups 
 
Table – 89 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 9011824.298 1 9011824.298 4.197E3 .000 
Group 2576.008 1 2576.008 1.200 .279 
Error 94472.492 44 2147.102   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table – 90 
 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 89445.677 1 89445.677 3.421E3 .000 
Group 40.344 1 40.344 1.543 .221 
Error 1150.591 44 26.150   
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BMI association in PLIF group 
Table -91 
wound inf * BMI_Categorised 
 
 
   BMI_Categorised 
Total    < 20 Between 20 to 25 > 25 
wound inf No Count 3 29 27 59
% within wound inf 5.1% 49.2% 45.8% 100.0%
Yes Count 0 4 1 5
% within wound inf .0% 80.0% 20.0% 100.0%
Total Count 3 33 28 64
% within wound inf 4.7% 51.6% 43.8% 100.0%
 
 
 
 
 
 
 
 
 
 
 
Table -92 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square 1.804a 2 .406 .503   
Likelihood Ratio 2.089 2 .352 .424   
Fisher's Exact Test 1.608   .503   
Linear-by-Linear Association .585b 1 .444 .687 .351 .230
N of Valid Cases 64      
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BMI association in Infective Spondylitis group 
Table -93 
 
 
UTI * BMI_Categorised 
 
 
   BMI_Categorised 
Total    < 20 Between 20 to 25 
UTI No Count 1 15 16
% within UTI 6.2% 93.8% 100.0%
Yes Count 3 9 12
% within UTI 25.0% 75.0% 100.0%
Total Count 4 24 28
% within UTI 14.3% 85.7% 100.0%
 
 
 
 
Table -94 
 
Chi-Square Tests
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square 1.969a 1 .161 .285 .196  
Continuity Correctionb .735 1 .391    
Likelihood Ratio 1.989 1 .158 .285 .196  
Fisher's Exact Test    .285 .196  
Linear-by-Linear Association 1.898c 1 .168 .285 .196 .172
N of Valid Cases 28      
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BMI association in Infective Spondylitis group 
 
Table -95 
 
wound inf * BMI_Categorised 
 
 
   BMI_Categorised 
Total    < 20 Between 20 to 25 
wound inf No Count 2 22 24
% within wound inf 8.3% 91.7% 100.0%
Yes Count 2 2 4
% within wound inf 50.0% 50.0% 100.0%
Total Count 4 24 28
% within wound inf 14.3% 85.7% 100.0%
 
 
 
 
 
Table -96 
 
Chi-Square Tests
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square 4.861a 1 .027 .086 .086  
Continuity Correctionb 2.054 1 .152    
Likelihood Ratio 3.653 1 .056 .086 .086  
Fisher's Exact Test    .086 .086  
Linear-by-Linear Association 4.688c 1 .030 .086 .086 .081
N of Valid Cases 28      
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BMI association in Unilateral TKR group 
Table -97 
 
 
wound inf * BMI_categorised 
 
 
   BMI_categorised 
Total    Between 20 to 25 >25 
wound inf No Count 29 16 45 
% within wound inf 64.4% 35.6% 100.0% 
Yes Count 3 2 5 
% within wound inf 60.0% 40.0% 100.0% 
Total Count 32 18 50 
% within wound inf 64.0% 36.0% 100.0% 
 
 
 
 
 
 
Table -98 
 
Chi-Square Tests
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square .039a 1 .844 1.000 .599  
Continuity Correctionb .000 1 1.000    
Likelihood Ratio .038 1 .845 1.000 .599  
Fisher's Exact Test    1.000 .599  
Linear-by-Linear Association .038c 1 .846 1.000 .599 .358
N of Valid Cases 50      
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BMI association in Bilateral TKR group 
Table -99 
UTI * BMI_categorised 
 
 
   BMI_categorised 
Total    Between 20 to 25 > 25 
UTI No Count 9 16 25
% within UTI 36.0% 64.0% 100.0%
Yes Count 1 0 1
% within UTI 100.0% .0% 100.0%
Total Count 10 16 26
% within UTI 38.5% 61.5% 100.0%
 
 
 
 
Table -100 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square 1.664a 1 .197 .385 .385  
Continuity Correctionb .058 1 .809    
Likelihood Ratio 1.976 1 .160 .385 .385  
Fisher's Exact Test    .385 .385  
Linear-by-Linear Association 1.600c 1 .206 .385 .385 .385
N of Valid Cases 26      
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BMI association in Bilateral TKR group 
Table -101 
 
 
wound inf * BMI_categorised 
 
 
   BMI_categorised 
Total    Between 20 to 25 > 25 
wound inf No Count 10 13 23 
% within wound inf 43.5% 56.5% 100.0% 
Yes Count 0 3 3 
% within wound inf .0% 100.0% 100.0% 
Total Count 10 16 26 
% within wound inf 38.5% 61.5% 100.0% 
 
 
 
 
Table -102 
 
 
Chi-Square Tests
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square 2.120a 1 .145 .262 .215  
Continuity Correctionb .681 1 .409    
Likelihood Ratio 3.154 1 .076 .262 .215  
Fisher's Exact Test    .262 .215  
Linear-by-Linear Association 2.038c 1 .153 .262 .215 .215
N of Valid Cases 26      
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BMI association in Unilateral THR group 
Table -103 
 
wound inf * BMI_categorised 
 
 
   BMI_categorised 
Total    Between 20 to 25 >25 
wound inf No Count 29 16 45
% within wound inf 64.4% 35.6% 100.0%
Yes Count 3 2 5
% within wound inf 60.0% 40.0% 100.0%
Total Count 32 18 50
% within wound inf 64.0% 36.0% 100.0%
 
 
 
 
 
Table -104 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) Point Probability 
Pearson Chi-Square .039a 1 .844 1.000 .599  
Continuity Correctionb .000 1 1.000    
Likelihood Ratio .038 1 .845 1.000 .599  
Fisher's Exact Test    1.000 .599  
Linear-by-Linear Association .038c 1 .846 1.000 .599 .358
N of Valid Cases 50      
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